- Home
- MMC vs BMY Comparison
MMC vs BMY Comparison
Compare MMC & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMC
- BMY
- Stock Information
- Founded
- MMC 1871
- BMY 1887
- Country
- MMC United States
- BMY United States
- Employees
- MMC N/A
- BMY N/A
- Industry
- MMC Specialty Insurers
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- MMC Finance
- BMY Health Care
- Exchange
- MMC Nasdaq
- BMY Nasdaq
- Market Cap
- MMC 104.0B
- BMY 115.3B
- IPO Year
- MMC N/A
- BMY N/A
- Fundamental
- Price
- MMC $230.04
- BMY $55.84
- Analyst Decision
- MMC Hold
- BMY Hold
- Analyst Count
- MMC 16
- BMY 14
- Target Price
- MMC $231.19
- BMY $58.00
- AVG Volume (30 Days)
- MMC 2.1M
- BMY 11.5M
- Earning Date
- MMC 04-17-2025
- BMY 02-06-2025
- Dividend Yield
- MMC 1.42%
- BMY 4.44%
- EPS Growth
- MMC 8.63
- BMY N/A
- EPS
- MMC 8.18
- BMY N/A
- Revenue
- MMC $24,458,000,000.00
- BMY $48,300,000,000.00
- Revenue This Year
- MMC $11.02
- BMY N/A
- Revenue Next Year
- MMC $5.94
- BMY N/A
- P/E Ratio
- MMC $28.11
- BMY N/A
- Revenue Growth
- MMC 7.57
- BMY 7.32
- 52 Week Low
- MMC $196.17
- BMY $39.35
- 52 Week High
- MMC $235.50
- BMY $61.10
- Technical
- Relative Strength Index (RSI)
- MMC 64.22
- BMY 45.21
- Support Level
- MMC $228.30
- BMY $53.54
- Resistance Level
- MMC $231.72
- BMY $56.54
- Average True Range (ATR)
- MMC 2.95
- BMY 1.41
- MACD
- MMC 0.33
- BMY -0.26
- Stochastic Oscillator
- MMC 89.58
- BMY 33.72
About MMC Marsh & McLennan Companies Inc.
Marsh McLennan is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (a management and economic consultancy). About half of its revenue is generated outside the US.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.